All news from Anaesthesiology

New Partnership for Early Intervention of T2DM

A new partnership in Leeds has been agreed to evaluate the benefits of a diagnostic blood test which can help predict whether someone is likely to develop type 2 diabetes. The test measures protein indicators or biomarkers in a blood sample. If the test is effective, it will enable GPs to work with their patients to find the best way to keep them healthy or to steer them towards better health.

Renal Cell Cancer: Support for Upfront Immunotherapy

In a phase 3 study of patients with previously untreated metastatic renal cell cancer (mRCC), use of the anti-PD-L1 immune checkpoint inhibitor atezolizumab (Tecentriq, Roche) in combination with bevacizumab (Avastin, Roche) delayed disease progression by about 3 months longer than standard treatment with sunitinib (Sutent, Pfizer), with fewer side effects.

FluChip-8G technology Aid in Pandemic Preparedness

InDevR Inc., a Boulder-based analytical technology and life science company, today announced plans to launch a Research Use Only (RUO) version of their FluChip-8G technology to aid in pandemic preparedness. The new molecular test addresses an unmet need for more detailed information about flu viruses found in human specimens without the data management complexities associated with current sequencing approaches. FluChip-8G offers viral subtype specific insight with the ease of use of an RT-PCR assay and unmatched simplicity in results interpretation.